Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VRT | GEV |
|---|---|---|
| Price | $243.48 | $951.57 |
| Change today | ▼ 2.13% | ▼ 0.03% |
| Market cap | $93.74B | $253.44B |
| Return, 3 months | -23.1% | -10.0% |
| Return, year to date | +50.4% | +45.9% |
| Return, 1 year | +72.1% | +51.6% |
| P/E (TTM) | 55.1 | 27.3 |
| P/B | 19.7 | 21.2 |
| P/E percentile vs own 5y | 32nd | 13th |
| Dividend yield | 0.09% | 0.21% |
| Revenue growth (YoY, latest qtr) | +24.1% | +21.9% |
| Net profit growth (YoY) | +53.5% | +31.9% |
| Gross margin | 38.0% | 20.2% |
| Operating margin | 19.4% | 4.4% |
| Net margin | 15.1% | 23.0% |
| Return on equity | 43.9% | 91.5% |
| Analyst target vs. price | +40.6% | +31.3% |
| Analyst buy share | 100% | 89% |
| RSI (14) | 46 | 49 |
| 30-day volatility | 59.3% | 47.5% |
| Max drawdown, 1 year | -40.7% | -25.5% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.